TMCnet News
Patient Perspectives and the Impact of Bioscience Innovation to be Highlighted at the 2016 Georgia Bio Innovation SummitJim Greenwood, CEO of the Biotechnology Innovation Organization, will lead a panel of experts on the impact of biosciences; while a luncheon patient panel will examine issues relating to access to the latest therapies, devices and cures at the 2016 Georgia Bio Innovation Summit, Wednesday, September 28 at Cobb Galleria. The annual Georgia Bio Innovation Summit has grown into a must-attend event for Georgia's bioscience community. The Summit provides a forum for professionals from industry, academia and government to discuss major trends and issues, including topics related to scientific research, product development, financing, business development and public policy. It is the one time each year companies and universities have the opportunity to showcase Georgia's bioscience innovation. We expect over 500 professionals from across Georgia, the Southeast and the nation to participate in this year's event. This year's Summit experience will highlight:
Georgia Bio (www.gabio.org) is the state's life science industry association whose members include pharmaceutical, biotechnology and medical device companies, medical centers, universities and research institutes, government groups and other business organizations involved in the development of life sciences related products and services. Note to Editors: Credentialed members of the news media are invited to attend. Registration is complimentary. Please contact Maria Thacker (404-920-2042; [email protected]).
View source version on businesswire.com: http://www.businesswire.com/news/home/20160926006010/en/ |